The new hampshire department of justice (NH DOJ) is the implementing state agency for the residential substance abuse treatment program for state prisoners (RSAT) grant

The New Hampshire Department of Justice (NH DOJ) has been awarded a $165,202 Residential Substance Abuse Treatment (RSAT) for State Prisoners Program formula grant from the Bureau of Justice Assistance (CFDA 16.593). The grant will support comprehensive, evidence-based substance use disorder (SUD) treatment and reentry services within three county jails in New Hampshire. Key activities will include conducting risk and needs assessments, providing random drug testing, and utilizing case managers to facilitate aftercare programming upon release. The grant will also enable the NH DOJ to release a competitive request for proposals (RFP) open to all ten county jails and the state Department of Corrections, with the goal of expanding RSAT program access and effectiveness across the state. Subgrantees will be required to offer holistic, client-centered aftercare and ensure frequent drug testing while participants engage in evidence-based treatment, including the availability of medication-assisted treatment (MAT). The grant period runs from October 1, 2024 to September 30, 2028.

Currently the NH DOJ has active RSAT funding subgrant programming in three of the states ten county jails. In conjunction with these programs, staff administers conduct risk and needs assessments, random drug testing, and and utilize a case manager to support aftercare services. Upon receiving the anticipated RSAT award, the NH DOJ will release a competitive request for proposals (RFP) that will be open for all ten county jails and the NH department of corrections, however, depending upon the number of eligible applications received will determine whether other available means to distribute the funding will be utilized to ensure RSAT funding is being utilized effectively and efficiently.subgrantees will be required to provide comprehensive, holistic, client-centered aftercare, and to closely monitor those individuals with substance use disorders. Subgrantees will need to ensure that random and frequent drug testing for participants while they participate in evidence-based treatment practices, both behind the wall and while in aftercare programming, which includes the availability of medical assistant treatment (mat).